In this interview, Bryn Williams-Jones comments on the hype surrounding pharmacogenomics: the financial opportunities and risks faced by the industry and governments, the promises to the patients and the issues of accessibility and ethics.
Bryn Williams-Jones on the hype in pharmacogenomics
(Length : 12 min. 50s.)
(Please be patient. Video should load and start automatically after a few seconds)
Direct video address:
Return to the dossier on:
|Guest :||Bryn Williams-Jones, Ph.D.|
|Journalist :||Helena Urfer, M.Sc.|